FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
Innoprax-5 Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
There is currently no usage information available for this product. We apologize for any inconvenience.
History
There is currently no drug history available for this drug.
Other Information
INNOPRAX-5® is comprised of 8 g of Amantadine HCl USP and 6 g of Gabapentin USP, 3 g of Diclofenac Sodium USP, 3 g of Baclofen USP, and 5 g of Lidocaine HCl USP for topical use.1 INNOPRAX-5® also contains a Cream Base containing purified water, white petrolatum, sorbitol solution, cetearyl alcohol, propylene glycol, ceteareth-20, simethicone, glyceryl monostearate, polyethylene glycol monostearate, sorbic acid and BHT. When mixed as instructed, the final product provides a homogeneous cream mixture containing Amantadine HCl, Gabapentin, Diclofenac Sodium, Baclofen, and Lidocaine HCl comparable to the active ingredients (Symmetrel®, Neurontin®, Voltaren Gel®, Lioresal® and Xylocaine®) contained in INNOPRAX-5®.
- 1
- Certificate of analysis on file
- 2
- This product is not manufactured by BMS Pharma. Co, manufacturer of Symmetrel ®, or by Pfizer Inc., manufacturer of Neurontin, or by Novartis Pharmaceuticals Corp., manufacturer of Voltaren Gel and Lioresal®, or by AstraZeneca LP, manufacturer of Xylocaine®.
Sources
Innoprax-5 Manufacturers
-
Accumix Pharmaceuticals
Innoprax-5 | Accumix Pharmaceuticals
The pharmacist must mix contents of each container with appropriate amount of Cream Base yielding a final volume of 100 grams at the time of dispensing. Pharmacist may utilize diluent(s) if needed from the respective active component Material Safety Data Sheet only. For topical use only. This product should not be administered orally.
Login To Your Free Account